Yanling Lu

Yanling is a technical leader with strong expertise in biologics development and manufacturing. She was initially trained as an applied chemist in China and later obtained her Master and PhD degrees in Physical Biochemistry in the UK. Prior to moving to Australia in 2009, she was a Senior Scientist in Bioprocess Development at MedImmune Cambridge UK (now AstraZeneca) leading antibody characterisation and formulation development. In the last 18 years, Yanling has led R&D teams in the biotech sector across UK, US and Australia. She has a track record of bringing discovery projects through development to commercialisation with her versatile skills and experiences covering drug discovery and development, assay development, process development & CMC, cGMP biomanufacturing, clinical trials and regulatory.

Yanling was involved in the development of two commercial therapeutic antibody products and led commercialisation of two cancer diagnostic tests. Currently Yanling manages all CMC programs at Glytherix to support preclinical and clinical development.

View All People